mutational profiles of mds patients undergoing allo-hsct
Published 4 years ago • 47 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
2:12
mutation profile in cmml undergoing allo-hsct
-
3:10
how mutation screening impacts transplant decisions in mds
-
2:44
the impact of mutation screening on transplant decisions in mds
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
1:36
insights into the biology of pediatric mds
-
0:58
options available to patients with tp53-mutated mds beyond stem cell transplantation
-
5:43
pre- and post-allohsct treatment in mds
-
1:18
key recurrent mutations in mds
-
17:05
your medical specialty based on personality | myers-briggs breakdown
-
21:38
drawing the line: the rationale behind blood tube collection order
-
4:38
the potential of mrd-adapted treatment in multiple myeloma
-
3:31
relevance of the ipss-r during sct in patients with mds in the molecular classification era
-
3:03
etiology and genetic profile of t-mds
-
2:56
the prognostic significance of mgus-like profiles in transplant-eligible patients with myeloma
-
2:48
how can mutational screening guide current clinical practice in mds?
-
2:12
the prevalence of germline runx1 mutations and their impact on allosct outcomes
-
1:55
diagnosing and treating aml: the role of mutational profiling
-
1:17
common germline mutations in myelodysplastic syndromes
-
2:15
optimizing transplantation for mds
-
2:18
prognostic factors and mutations in mds
-
1:39
germline predisposition to clonal hematopoiesis and its role in leukemia progression